Physician profile
Alfredo T Iloreta
NPI 1790751576
$1,363.81
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $308 · 2021: $179 · 2022: $20.36 · 2023: $115 · 2024: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.39 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $460.89 | 2019-2023 | Myrbetriq |
| Pfizer INC. | $146.25 | 2019-2024 | |
| Janssen Biotech, INC. | $137.24 | 2019-2020 | |
| Abbvie INC. | $59.64 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $55.14 | 2024 | Prolaris |
| Profound Medical Corp. | $54.82 | 2021 | |
| Blue Earth Diagnostics | $43.76 | 2019-2021 | |
| Boston Scientific Corporation | $41.91 | 2022-2024 | Greenlight Xps |
| Sumitomo Pharma America, INC. | $39.98 | 2023-2024 | Gemtesa |
| Endo Pharmaceuticals INC. | $30.68 | 2021 | |
| Teleflex LLC | $29.56 | 2024 | Urolift |
| Myovant Sciences INC. | $25.21 | 2021 | |
| Janssen Scientific Affairs, LLC | $24.51 | 2019 | |
| Medtronic, INC. | $23.16 | 2024 | Interstim |
| Becton, Dickinson and Company | $20.27 | 2024 | Bard Urinary Drainage Bag |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $20.05 | 2020 | |
| Ambu INC. | $19.98 | 2024 | |
| Ferring Pharmaceuticals INC. | $17.62 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $17.46 | 2019 | |
| Cook Medical LLC | $15.92 | 2019 | |
| Karl Storz Endoscopy-America | $14.24 | 2019 | |
| Coloplast Corp | $14.19 | 2019 | |
| Olympus America INC. | $14.11 | 2019 | |
| Allergan, INC. | $13.94 | 2020 | |
| Urogen Pharma, INC. | $12.01 | 2020 | |
| Rochester Medical Corporation | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfredo Iloreta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.